Mirati Therapeutics, Inc.

MARSHALL WACE, LLP

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

147,144

Value ($000)

6,410

Weight

0.0%

2019 Q4 - 2023 Q3 (10 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	6,410	0.0%	147,144	9/30/2023
2023 Q2	8/14/2023	21,112	0.0%	584,323	6/30/2023
2023 Q1	5/15/2023	20,546	0.1%	552,614	3/31/2023
2021 Q4	2/14/2022	12,229	0.0%	83,364	12/31/2021
2021 Q3	11/15/2021	7,117	0.0%	40,232	9/30/2021
2021 Q2	8/13/2021	7,221	0.0%	44,702	6/30/2021
2021 Q1	5/17/2021	8,144	0.0%	47,544	3/31/2021
2020 Q4	2/16/2021	81,401	0.5%	370,606	12/31/2020
2020 Q3	11/16/2020	71,136	0.5%	428,399	9/30/2020
2019 Q4	2/14/2020	964	0.0%	7,482	12/31/2019